HIHCNi002-A

Registration Summary:

A P E C

iPSC-SCA3

The cell line is not submitted yet.

(only basic data is shown)

General

iPSC Line
hPSCreg name	HIHCNi002-A
Cite as:	HIHCNi002-A (RRID:CVCL_VL41)
Alternative name(s)	iPSC-SCA3
iPSC line type	Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines	No similar lines found.
Last update	14th April 2018
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Hertie Institute for Clinical Brain Research - Clinical Neurogenetics (HIHCN)
External iPSC Databases
Cellosaurus	CVCL_VL41
Wikidata	Q94208294
General iPSC Information
Publications	Harmuth T et al. Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3. Frontiers in molecular neuroscience. 2018;11:368. Hayer SN et al. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A. Stem cell research. 2018 Jul;30:171-174. Harmuth T et al. Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3. Front Mol Neurosci. 2018-10-10. Moore LR et al. Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line. Stem cell research. 2019 Aug;39:101504. Wang AYL et al. Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications. Cell transplantation. 2019 Dec;28(1_suppl):112S-131S. He L et al. Human stem cell models of polyglutamine diseases: Sources for disease models and cell therapy. Experimental neurology. 2021 Mar;337:113573. Gonsior K et al. PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study. Journal of neurology. 2021 Apr;268(4):1304-1315. Pereira Sena P et al. Pathophysiological interplay between O-GlcNAc transferase and the Machado-Joseph disease protein ataxin-3. Proceedings of the National Academy of Sciences of the United States of America. 2021 Nov 23;118(47). Hommersom MP et al. Human Induced Pluripotent Stem Cell-Based Modelling of Spinocerebellar Ataxias. Stem cell reviews and reports. 2022 Feb;18(2):441-456. Hauser S et al. Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons. Molecular therapy. Nucleic acids. 2022 Mar 8;27:99-108. Abeditashi M et al. KPNB1 modulates the Machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP. Cellular and molecular life sciences : CMLS. 2022 Jul 6;79(8):401. Coelho P et al. Mitochondrial function and dynamics in neural stem cells and neurogenesis: Implications for neurodegenerative diseases. Ageing research reviews. 2022 Sep;80:101667.

iPSC Derivation

General